Venous Thromboembolic Disease: Clinical Trials

2 trials for Venous Thromboembolic Disease, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 unknown. 2 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 42Completed 1, Unknown 1

Follow Venous Thromboembolic Disease: new trials by email Literature Review of Venous Thromboembolic Disease trials Research Report on Venous Thromboembolic Disease

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Screening for Cancer in Patients With Unprovoked VTE
Fludeoxyglucose 18F - Venous Thromboembolic Disease, Respiratory Disease
Phase 4UnknownFundación Pública Andaluza para la gestión de la Investigación en Sevilla6502019-10-232021-12-09
Venous Thromboembolic Prophylaxis After Trauma: Three Times a Day Unfractionated Heparin Versus Twice a Day Enoxaparin
5000 Units unfractionated Heparin Q 8 hr, 30mg enoxaparin Q12 hr - Venous Thromboembolic Disease, Deep Vein Thrombosis
Phase 4CompletedScripps Health4952012-11-012016-07-18

Narrower conditions

Pulmonary Embolism (2)  ·  Venous Thrombosis (2)  ·  Lung Diseases (1)  ·  Respiration Disorders (1)  ·  Wounds and Injuries (1)

Broader conditions

Cardiovascular Diseases (2)  ·  Embolism (2)  ·  Embolism and Thrombosis (2)  ·  Respiratory Tract Diseases (2)  ·  Thrombosis (2)  ·  Vascular Diseases (2)  ·  Lung Diseases (1)

Interventions

Enoxaparin (1)  ·  Fluorodeoxyglucose F18 (1)  ·  Heparin, Low-Molecular-Weight (1)

Sponsors

Fundación Pública Andaluza para la gestión de la Investigación en Sevilla (1)  ·  Scripps Health (1)

Countries

Spain (1)  ·  United States (1)

Top investigators

Luis Jara Palomares, MD/PhD (1)  ·  Steven R Shackford, MD (1)

Results publications

PMID 39971173

NIH funding

2018 (1)